E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 1.29% in Afternoon Trade, Latest Price at HKD 14.940
NewTimeSpace News: As of 15:08 on July 6, E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) was up 1.29%, with the latest price at HKD 14.940, today's opening price at HKD 14.750, the highest price at HKD 15.230, the lowest price at HKD 14.750, and an intraday amplitude of 3.25%. The ETF traded 101,000 shares, with a turnover of HKD 1.5272 Million, and an average price of HKD 15.121. The current Net Asset Value (NAV) is HKD 14.745, Assets Under Management (AUM) are HKD 29.4889 Million, total issued shares are 2.00 Million, and each lot consists of 100 shares.
E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) tracks the Solactive Select Biotech Index, whose constituent stocks cover multiple innovative regions including China, the United States, Europe and Israel.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares Newly Listed Stocks Tracking Weekly Report: B&K CORP-B Leads with 68% Weekly Gain; INNOGEN-B Down Over 45% Cumulatively in Two Weeks Since Lock-up Expiry - 20260821
- METIS TECHBIO-P (07666.HK): Added as Hang Seng Composite Index Constituent, Effective 7 September
- SUNSHINE OIL (02012.HK): Subsidiary Holds 40% Stake in New Joint Venture to Build 6,000P Computing Power Centre
- CH GENERAL EDU (02175.HK): Target Company Unlikely to Meet 2026 Net Profit Target; Agreement in Principle to Reduce Acquisition Consideration
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion